Intra Cellular Therapiesincis A Biopharmaceutical Company Dedicated To Developing Innovative Treatments For Neuropsychiatric And Neurological Disordersfounded On Nobel Prize Winning Research By Drpaul Greengardthe Company Focuses On Therapies That Target Intracellular Signaling Pathways To Address Central Nervous System Diseasesthe Company S Mission Is To Improve The Lives Of Individuals With Neuropsychiatric And Related Disorders While Alleviating Burdens On Patients And Caregiversin 2021Intra Cellular Received Fda Approval For Caplytaa Lumateperoneto Treat Depressive Episodes In Bipolar I Ii Disorderand It Has Submitted A New Drug Application For Its Use As Adjunctive Therapy For Major Depressive Disorderthe Company Is Headquartered In New Yorknyand Employs Approximately 860 People
No conferences found for this company.
| Company Name | Intra Cellular Therapies Inc |
| Country |
United States
|
| Address | 430 East 29Th Street 900 New York Ny 10016 |
| Telephone | Login to View |
| Login to View |
